 |
|
Migraine Is Associated With Magnetic Resonance Imaging White Matter Abnormalities
A Meta-analysis
Richard H. Swartz, BSc(Hon), PhD;
Ralph Z. Kern, MD, MHSc, FRCPC
Arch Neurol. 2004;61:1366-1368.
ABSTRACT
| |
Background There is controversy as to whether migraine is associated with white matter abnormalities (WMAs) on magnetic resonance images. These abnormalities may be important as a risk factor for future stroke. Further, it is controversial whether any increased risk of WMAs is attributable to comorbidities such as vascular disease.
Methods A meta-analysis of published case-control studies was undertaken to address the relationship between migraine and magnetic resonance imaging WMAs. Seven studies were identified. Data from studies reporting the incidence of magnetic resonance imaging WMAs in those with migraine and appropriate control populations were used to calculate odds ratios for WMAs in migraine for each study. A stratified meta-analysis was performed using studies that did and did not exclude subjects with disease comorbidities.
Results The summary odds ratio shows that those with migraine are at increased risk for WMAs (odds ratio, 3.9 [95% confidence interval, 2.26-6.72]). The risk does not differ between studies that included subjects with comorbidities and those that did not.
Conclusion This meta-analysis demonstrates that subjects with migraine are at higher risk of having WMAs on magnetic resonance images than those without migraine. This increased risk is present even in younger individuals who do not have co-occurring cerebrovascular disease risk factors. Prospective studies are needed to determine whether the increased risk of stroke in migraine is mediated or foreshadowed by the presence of WMAs.
INTRODUCTION
Migraine headaches are a common and significant cause of disability in our society.1 White matter abnormalities (WMAs) on magnetic resonance images (MRIs) can be seen with migraine, but they are also incidental findings in normal control populations. Magnetic resonance imaging WMAs are more common in individuals with cerebrovascular risk factors.2 There are conflicting studies showing either increased incidence3-6 or equal incidence7-9 of WMAs in subjects with migraine compared with those without migraine. Studies that report no increased incidence of WMAs imply that the reported increase can be accounted for by disease comorbidities, such as age, hypertension, diabetes, or demyelinating diseases. To resolve this issue, a meta-analysis was performed to identify published studies of MRI WMAs in subjects with migraine and healthy controls. Data from these studies were evaluated and, where appropriate, combined to ask 2 questions: (1) Are subjects with migraine at higher risk of having WMA on MRI than those without? (2) What is the risk of WMAs in subjects with migraine who do not have co-occurring cerebrovascular disease risk factors?
METHODS
A MEDLINE literature search was performed using Entrez PubMed (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) using the keywords "MRI," "migraine," and "white matter" to identify studies that have investigated MRI signal abnormalities in subjects with migraine headaches. The search was limited to English-language publications and studies of humans only. Eligible studies focused on structural MRI signal abnormalities, while studies of diffusion tensor signal, magnetic resonance spectroscopy, or functional imaging techniques were excluded. Studies of specific diseases associated with headache (eg, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL], arteriovenous malformations, or aneurysms) were excluded. Data from studies reporting the incidence of MRI WMAs in those with migraine and appropriate control populations were used to calculate odds ratios (ORs) for WMAs in migraine for each study. A stratified meta-analysis was performed with a random-effects model10 using RevMan Analysis (version 4.2.3, http://www.cc-ims.net/RevMan, November 2003; Cochrane Collaboration, Oxford, England). Separate analyses were performed for: (1) studies that excluded subjects with disease comorbidities and (2) studies that did not exclude subjects based on comorbidities. The level of significance was set at  = .0125 to account for 3 comparisons.
RESULTS
The Medline search identified 46 articles. Of these, 7 retrospective case-control studies were found that examined structural MRI signal abnormalities in individuals with migraine compared with control samples without migraine (Table). There were no prospective studies. One study compared signal abnormalities in both the spinal cord and brain.12 Only the brain imaging data from that study were included in the present analysis. The numbers of subjects with WMAs from the migraine and control groups are shown in the Table. Three of the 7 studies did not exclude patients based on the presence of comorbidities that might result in WMAs on MRI. In the 4 studies that selected patients to be free of comorbidities, reasons for exclusion included age, cerebrovascular disease risk factors (hypertension, hypercholesterolemia, diabetes mellitus), CADASIL, demyelinating diseases, inflammatory conditions, and valvular heart disease.
|
|
|
|
Table. Incidence of White Matter Abnormalities (WMAs) in Migraine and Control Groups From the 7 Eligible Studies
|
|
|
Odds ratios from the 7 studies and the meta-analysis summary are shown in Figure 1. Tests for heterogeneity13 show that the results of the 7 studies are not heterogeneous ( 26 = 4.13; P = .66; heterogeneity = 0.34). The summary OR suggests that individuals with migraine are close to 4 times more likely to have WMAs than controls (OR, 3.90 [95% confidence interval (CI), 2.26-6.72]).
|
|
|
|
Figure 1. Plot of odds ratios (ORs) and 95% confidence intervals (CIs) from the 7 eligible studies.
|
|
|
Data from the 4 studies that excluded individuals with disease comorbidities are shown in Figure 2. These data show that, after controlling for comorbidities, those with migraine are still more likely to have WMAs compared with controls (OR, 4.14 [95% CI, 2.05-8.37]; test of heterogeneity: 23 = 2.49; P = .48; heterogeneity = 0.526).
|
|
|
|
Figure 2. Plot of odds ratios (ORs) and 95% confidence intervals (CIs) from the 4 studies that excluded participants with comorbidities that could cause white matter abnormalities.
|
|
|
Data from the 3 studies that did not select patients based on comorbidities are shown in Figure 3. The OR from these studies was not greater than the OR from the studies that excluded comorbidities (OR, 3.56 [95% CI, 1.51-8.42]; test of heterogeneity: 22 = 1.65; P = .44; heterogeneity = 0.64).
|
|
|
|
Figure 3. Plot of odds ratios (ORs) and 95% confidence intervals (CIs) from the 3 studies that did not exclude participants with comorbidities that could cause white matter abnormalities.
|
|
|
COMMENT
The results from this meta-analysis demonstrate that subjects with migraine are at higher risk of having WMA on MRI than those without migraine. In addition, this increased risk is present even in younger individuals who do not have co-occurring cerebrovascular disease risk factors. While it is recognized that migraine confers an increased risk of stroke,14 the relationship between migraine and silent white matter changes has been more controversial. Several authors have suggested that there is no relationship between migraine and WMA after excluding cerebrovascular disease risk factors or other disease comorbidities related to MRI signal changes.7-9 The data presented here show that there is a strong relationship between migraine and MRI WMA, regardless of comorbidities. Individuals with migraine are close to 4 times more likely to show these changes than age- and sex-matched controls. This applies even to studies of young (55 years) people with no other identified risk factors beyond migraine.
This may be significant since white matter hyperintensities are related to an increased risk of stroke.15 Indeed, having migraine increases the risk of stroke in young people.16 The same pathophysiologic characteristics that predisposes individuals to migraine may underlie the increased risk of stroke. This raises the intriguing possibility that pharmacological therapy for migraine prophylaxis could reduce the long-term risk of both silent and symptomatic strokes. It has been suggested that the concept of disease modification in migraine may have come of age.17 Our observations lend support to this claim. Prospective trials evaluating this hypothesis need to be undertaken.
The presence of MRI WMA may reflect pathologic conditions other than ischemia, such as demyelinating disease, CADASIL, or other connective tissue disease. The studies reviewed in the present analysis did not report the volume or number of white matter changes, but in most migraine-related WMA the changes are multiple, small, deep white matter or small and periventricular in location. Extensive periventricular abnormalities or large lacunar infarcts in the deep white matter or deep gray matter nuclei should increase suspicion for other processes (eg, CADASIL or small-vessel disease, respectively). Therefore, careful clinical correlation would be required before ascribing the observed WMA to migraine. Other investigations such as cerebrospinal fluid analysis or appropriate serologic tests may be indicated and should be ascertained on a case-by-case basis.
There are several important limitations to this study. First, by definition, a meta-analysis of published literature has a selection bias; negative results are more difficult to publish. Second, none of the studies were population-based analyses of all individuals in a cohort with and without migraine. The selection of individuals for study could thus have been biased as well. Third, some of the identified WMA may represent enlarged Virchow-Robin spaces and not vascular injury. However, this is considerably less likely in the adult population than in children with migraine.18 Finally, this analysis did not explore differences with migraine subtypes (such as differences between those with and without aura).
Despite these limitations, the data reviewed here suggest that individuals with migraine are 4 times more likely than subjects without migraine to have white matter changes when MRI is performed and that this cannot be explained by the presence of disease comorbidities. These white matter changes may be a marker for subsequent risk of stroke. It remains to be prospectively evaluated whether those people who have migraine and WMA are at greater risk of stroke than those with migraine but without WMA.
AUTHOR INFORMATION
Correspondence: Ralph Z. Kern, MD, MHSc, FRCPC, Mount Sinai Hospital, 431-600 University Ave, Toronto, Ontario M5G 1X5, Canada (rkern@mtsinai.on.ca).
Accepted for Publication: January 2, 2004.
Author Contributions: Study concept and design: Swartz and Kern. Acquisition of data: Swartz and Kern. Analysis and interpretation of data: Swartz and Kern. Drafting of the manuscript: Swartz and Kern. Critical revision of the manuscript for important intellectual content: Swartz and Kern. Statistical expertise: Swartz and Kern. Administrative, technical, and material support: Kern. Study supervision: Kern.
Author Affiliations: Mount Sinai Hospital, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario.
REFERENCES
| |
1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
FULL TEXT
|
ISI
| PUBMED
2. Schmidt R, Fazekas F, Kleinert G, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: a comparative study between stroke patients and normal volunteers. Arch Neurol. 1992;49:825-827.
FREE FULL TEXT
3. de Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache. 1995;35:264-268.
FULL TEXT
|
ISI
| PUBMED
4. Pavese N, Canapicchi R, Nuti A, et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia. 1994;14:342-345.
FULL TEXT
|
ISI
| PUBMED
5. Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia. 1991;11:69-74.
FULL TEXT
|
ISI
| PUBMED
6. Robbins L, Friedman H. MRI in migraineurs. Headache. 1992;32:507-508.
FULL TEXT
|
ISI
| PUBMED
7. Cooney BS, Grossman RI, Farber RE, Goin JE, Galetta SL. Frequency of magnetic resonance imaging abnormalities in patients with migraine. Headache. 1996;36:616-621.
FULL TEXT
|
ISI
| PUBMED
8. Ziegler DK, Batnitzky S, Barter R, McMillan JH. Magnetic resonance image abnormality in migraine with aura. Cephalalgia. 1991;11:147-150.
FULL TEXT
|
ISI
| PUBMED
9. Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. Am J Neuroradiol. 1991;12:521-524.
ABSTRACT
10. Petitti DB. Meta-Analysis, Decision Analysis And Cost-Effectiveness Analysis: Methods For Quantitative Synthesis In Medicine. 2nd ed. New York, NY: Oxford University Press; 2000.
11. Fazekas F, Koch M, Schmidt R, et al. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache. 1992;32:287-291.
FULL TEXT
|
ISI
| PUBMED
12. Rovaris M, Bozzali M, Rocca MA, Colombo B, Filippi M. An MR study of tissue damage in the cervical cord of patients with migraine. J Neurol Sci. 2001;183:43-46.
FULL TEXT
|
ISI
| PUBMED
13. Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
FULL TEXT
|
ISI
| PUBMED
14. Low NC, Merikangas KR. The comorbidity of migraine. CNS Spectr. 2003;8:433-444.
ISI
| PUBMED
15. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126-1129.
FREE FULL TEXT
16. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral is- chaemia in young adults: the Italian National Research Council Study Group on stroke in the young. Lancet. 1996;347:1503-1506.
ISI
| PUBMED
17. Loder E, Biondi D. Disease modification in migraine: a concept that has come of age? Headache. 2003;43:135-143.
FULL TEXT
|
ISI
| PUBMED
18. Schick S, Gahleitner A, Wober-Bingol C, et al. Virchow-Robin spaces in childhood migraine. Neuroradiology. 1999;41:283-287.
FULL TEXT
|
ISI
| PUBMED
SECTION EDITOR: DAVID E. PLEASURE, MD
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Is patent foramen ovale closure indicated for migraine?: Patent Foramen Ovale Closure for Migraine
Reisman and Fuller
Circ Cardiovasc Interv 2009;2:468-474.
FULL TEXT
Migraine and Cerebral Infarct-like Lesions on MRI: An Observation, Not a Disease
Kurth and Tzourio
JAMA 2009;301:2594-2595.
FULL TEXT
Morphing voxels: the hype around structural imaging of headache patients
May
Brain 2009;132:1419-1425.
ABSTRACT
| FULL TEXT
MRI in the diagnosis of pediatric multiple sclerosis
Callen et al.
Neurology 2009;72:961-967.
ABSTRACT
| FULL TEXT
Clinical course in migraine: Conceptualizing migraine transformation
Bigal and Lipton
Neurology 2008;71:848-855.
ABSTRACT
| FULL TEXT
Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
Adami et al.
Neurology 2008;71:101-107.
ABSTRACT
| FULL TEXT
Endothelial repair capacity and migraine: The fix is in
Elkind
Neurology 2008;70:1506-1507.
FULL TEXT
Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study
Schulz et al.
Brain 2007;130:3102-3110.
ABSTRACT
| FULL TEXT
Migraine Mediates the Influence of C677T MTHFR Genotypes on Ischemic Stroke Risk With a Stroke-Subtype Effect
Pezzini et al.
Stroke 2007;38:3145-3151.
ABSTRACT
| FULL TEXT
Case 21-2007 -- A 58-Year-Old Woman with Headaches, Weakness, and Strokelike Episodes
Greer et al.
NEJM 2007;357:164-173.
FULL TEXT
How migraines impact cognitive function: Findings from the Baltimore ECA
Kalaydjian et al.
Neurology 2007;68:1417-1424.
ABSTRACT
| FULL TEXT
Migraine and cognitive function: Some reassuring news
Elkind and Scher
Neurology 2005;64:590-591.
FULL TEXT
Migraines and White-Matter Abnormalities
JWatch Psychiatry 2004;2004:8-8.
FULL TEXT
|
